Unsecured Debt Consolidation Loan – S&P: Boston Scientific Corp.’s $300 Million Senior Unsecured Debt – Phramalive.com
S&P: Boston Scientific Corp.’s $300 Million Senior Unsecured Debt – Phramalive.comBOSTON, Dec. 17, 2009–Standard & Poor’s Ratings Services said today that it assigned its ‘BBB-’ debt rating to Boston Scientific Corp.’s $300 million 7.375% senior unsecured debt due 2040. On Dec. 10, 2009, we assigned our ‘BBB-’ rating to the Source: www.pharmalive.com
AIG [...]